Spots Global Cancer Trial Database for Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer
Official Title: A Randomized, Double-Blind, Phase II Trial of CT-322 (BMS-844203) Plus Irinotecan, 5-FU and Leucovorin (FOLFIRI) Versus Bevacizumab Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer
Study ID: NCT00851045
Conditions
Study Description
Brief Summary: The purpose of this study is to determine the efficacy of CT-322 comparative to bevacizumab, both in combination with irinotecan, 5-FU and leucovorin in the second-line treatment of subject with metastatic colorectal cancer
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Acrc/Arizona Clinical Research Center, Inc., Tucson, Arizona, United States
Compassionate Cancer Care Medical Group Inc, Fountain Valley, California, United States
Compassionate Cancer Care Medical Group, Inc, Riverside, California, United States
Sharp Memorial Hospital, San Diego, California, United States
Florida Cancer Specialists, Fort Myers, Florida, United States
Midwest Center For Hematology/Oncology, Joliet, Illinois, United States
Cancer Center Of Kansas, Wichita, Kansas, United States
Gurtler, Jayne, Metairie, Louisiana, United States
Guthrie Clinic, Ltd, Sayre, Pennsylvania, United States
Pharma Resource, East Providence, Rhode Island, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
University Of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
Local Institution, Bahia Blanca, Buenos Aires, Argentina
Local Institution, Capital Federal, Buenos Aires, Argentina
Local Institution, Terni, , Italy
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
